Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U S A 106, 9362−9367 (2009).

  2. 2.

    et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087–1093 (2007).

  3. 3.

    et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. USA 106, 9362–9367 (2009).

  4. 4.

    et al. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet. 5, e1000597 (2009).

  5. 5.

    Anonymous. On beyond GWAS. Nat. Genet. 42, 551 (2010).

  6. 6.

    , & Finding genes that underlie complex traits. Science 298, 2345–2349 (2002).

  7. 7.

    et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum. Mol. Genet. 18, 1692–1703 (2009).

  8. 8.

    , & The 1000 Genomes Project: new opportunities for research and social challenges. Genome Med. 2, 3 (2010).

  9. 9.

    et al. In search of causal variants: refining disease association signals using cross-population contrasts. BMC Genet. 9, 58 (2008).

  10. 10.

    et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108–112 (2009).

  11. 11.

    et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854–858 (2009).

  12. 12.

    , & Genomic views of distant-acting enhancers. Nature 461, 199–205 (2009).

  13. 13.

    et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799–816 (2007).

  14. 14.

    et al. ChIP-Seq identification of weakly conserved heart enhancers. Nat. Genet. 42, 806–810 (2010).

  15. 15.

    et al. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat. Genet. 42, 631–634 (2010).

  16. 16.

    et al. A systematic approach to understand the functional consequences of non-protein coding risk regions. Cell Cycle 9, 47–51 (2010).

  17. 17.

    et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 41, 882–884 (2009).

  18. 18.

    et al. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl. Acad. Sci. USA 107, 9742–9746 (2010).

  19. 19.

    , & An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res. 20, 1191–1197 (2010).

  20. 20.

    et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464, 1071–1076 (2010).

  21. 21.

    et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. USA 106, 11667–11672 (2009).

  22. 22.

    & The epigenomics of cancer. Cell 128, 683–692 (2007).

  23. 23.

    et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129, 879–890 (2007).

  24. 24.

    et al. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc. Natl. Acad. Sci. USA 103, 982–987 (2006).

  25. 25.

    & Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253–262 (2007).

  26. 26.

    et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315–322 (2009).

  27. 27.

    et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat. Genet. 38, 1178–1183 (2006).

  28. 28.

    , & Germline epimutation of MLH1 in individuals with multiple cancers. Nat. Genet. 36, 497–501 (2004).

  29. 29.

    , & Epimutations and cancer predisposition: importance and mechanisms. Curr. Opin. Genet. Dev. 20, 290–298 (2010).

  30. 30.

    et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat. Genet. 40, 904–908 (2008).

  31. 31.

    & MicroRNA binding site polymorphisms as biomarkers of cancer risk. Expert Rev. Mol. Diagn. 10, 817–829 (2010).

  32. 32.

    , , & Variable tandem repeats accelerate evolution of coding and regulatory sequences. Annu. Rev. Genet. 44, 445–477 (2010).

  33. 33.

    et al. Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. Nat. Genet. 38, 1341–1347 (2006).

  34. 34.

    et al. Nonallelic transvection of multiple imprinted loci is organized by the H19 imprinting control region during germline development. Genes Dev. 23, 2598–2603 (2009).

  35. 35.

    et al. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. J. Clin. Invest. 117, 2611–2620 (2007).

  36. 36.

    et al. The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia. Nat. Genet. 38, 1245–1247 (2006).

  37. 37.

    et al. Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am. J. Hum. Genet. 76, 794–803 (2005).

  38. 38.

    et al. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6, e1000888 (2010).

  39. 39.

    et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470–473 (2007).

  40. 40.

    et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466, 714–719 (2010).

  41. 41.

    et al. Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet. 6, e1000932 (2010).

  42. 42.

    et al. Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis. PLoS Genet. 6, e1001204 (2010).

  43. 43.

    et al. Genetic inheritance of gene expression in human cell lines. Am. J. Hum. Genet. 75, 1094–1105 (2004).

  44. 44.

    et al. Genetic analysis of genome-wide variation in human gene expression. Nature 430, 743–747 (2004).

  45. 45.

    et al. Genome-wide associations of gene expression variation in humans. PLoS Genet. 1, e78 (2005).

  46. 46.

    et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 422, 297–302 (2003).

  47. 47.

    et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302, 2141–2144 (2003).

  48. 48.

    & Genetics of global gene expression. Nat. Rev. Genet. 7, 862–872 (2006).

  49. 49.

    & Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat. Rev. Genet. 10, 595–604 (2009).

  50. 50.

    , , , & Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 10, 184–194 (2009).

  51. 51.

    et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107 (2008).

  52. 52.

    Genome-wide allele-specific analysis: insights into regulatory variation. Nat. Rev. Genet. 11, 533–538 (2010).

  53. 53.

    et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464, 773–777 (2010).

  54. 54.

    et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464, 768–772 (2010).

  55. 55.

    et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 7 Suppl 1, S7 (2006).

  56. 56.

    & Methods for the inference of biological pathways and networks. Methods Mol. Biol. 541, 225–245 (2009).

  57. 57.

    et al. Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells. Proc. Natl. Acad. Sci. USA 102, 9176–9181 (2005).

  58. 58.

    et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 8, 149–163 (2010).

Download references

Acknowledgements

We would like to thank F. Bunz and all the members of the NIH Post-Genome Wide Association Initiative for helpful discussions and, in particular, I. Tomlinson (Wellcome Trust Centre for Human Genetics, Oxford). The contributing groups are supported by funding made available through the NIH Post-Genome Wide Association Initiative in response to Call (http://grants.nih.gov./grants/oer.htm). This Call sustains research across five cancer organ sites (prostate: 1U19CA148537-01; breast: 1U19CA148065-01; ovarian: 1U19CA148112-01; colorectal: 1U19CA148107-01; and lung: 1U19CA148127-01). For further information on this Initiative, please refer to the website: (http://epi.grants.cancer.gov/). In addition, this article is the product of the first attempt to engage the entire scientific community in the drafting of a scientific paper through open-access websites. We would like to thank R. Hoffmann at WikiGenes for hosting the pre-submission version of this submission (http://www.wikigenes.org/e/pub/e/84.html) and his unstinting energy and enthusiasm for this project and also Nature Precedings for hosting the same version (http://precedings.nature.com/documents/5162/version/1).

Author information

Affiliations

  1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

    • Matthew L Freedman
  2. The Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

    • Matthew L Freedman
  3. Cancer Epidemiology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

    • Alvaro N A Monteiro
  4. University of Southern California, Keck School of Medicine, Los Angeles, California, USA.

    • Simon A Gayther
  5. Translational Research Laboratory, University College London Elizabeth Garrett Anderson Institute for Women's Health (EGA), London, UK.

    • Simon A Gayther
  6. Department of Urology, Norris Cancer Center, University of Southern California, Los Angeles, California, USA.

    • Gerhard A Coetzee
  7. German Cancer Research Center, Division of Epigenomics and Cancer Risk Factors, Heidelberg, Germany.

    • Angela Risch
    •  & Christoph Plass
  8. Department of Preventive Medicine, University of Southern California, Los Angeles, California, USA.

    • Graham Casey
  9. Department of Neuroscience, Baylor College of Medicine, Houston, Texas, USA.

    • Mariella De Biasi
  10. Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

    • Chris Carlson
  11. Translational Genomics Research Institute (TGen), Phoenix, Arizona, USA.

    • David Duggan
  12. Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

    • Michael James
    • , Pengyuan Liu
    • , Jay W Tichelaar
    • , Haris G Vikis
    •  & Ming You
  13. Norwegian Centre for Molecular Medicine, Nordic European Molecular Biology Laboratory (EMBL) Partnership, University of Oslo, Oslo, Norway.

    • Ian G Mills
  14. Uro-Oncology Research Group, Cancer Research UK Cambridge Research Institute, Cambridge, UK.

    • Ian G Mills

Authors

  1. Search for Matthew L Freedman in:

  2. Search for Alvaro N A Monteiro in:

  3. Search for Simon A Gayther in:

  4. Search for Gerhard A Coetzee in:

  5. Search for Angela Risch in:

  6. Search for Christoph Plass in:

  7. Search for Graham Casey in:

  8. Search for Mariella De Biasi in:

  9. Search for Chris Carlson in:

  10. Search for David Duggan in:

  11. Search for Michael James in:

  12. Search for Pengyuan Liu in:

  13. Search for Jay W Tichelaar in:

  14. Search for Haris G Vikis in:

  15. Search for Ming You in:

  16. Search for Ian G Mills in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Ian G Mills.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/ng.840

Further reading